Ϫ/Ϫ mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity. Am
signaling molecules acting through nuclear receptors [e.g., the farnesoid X receptor (FXR)], G protein-coupled receptors (e.g., TGR5), and other cell-signaling pathways to modulate their own levels, as well as triglyceride, cholesterol, glucose, and energy metabolism (8, 9, 14, 16, 34) .
Bile acids activate the FXR and then decrease their own synthesis through two signaling pathways that regulate cholesterol 7␣-hydroxylase (CYP7A1). FXR activation increases expression of the short heterodimer partner (SHP), which interacts with the liver receptor homolog-1 and prevents liver receptor homolog-1 from associating with and activating CYP7A1 (14) . In the ileum, activation of the FXR by bile acids increases release of FGF15 and FGF19 (mouse and human forms, respectively), which activates FGF receptor 4 in the liver to repress Cyp7a1 expression and, thus, decrease bile acid synthesis (16) . In addition, the FXR decreases expression of the apical sodium-dependent bile acid transporter (ASBT) and increases expression of the organic solute transporter ␣-and ␤-subunits (OST␣ and OST␤) (2, 21) . These changes are expected to reduce the concentration of bile acids in the enterocyte and decrease bile acid movement through the enterohepatic circulation. FXR activation also reduces de novo lipogenesis by decreasing expression of sterol regulatory element-binding protein 1c (SREBP1c) and its target genes and improves glucose tolerance and insulin sensitivity (14) . In particular, the FXR target FGF19 increases metabolic rate, decreases adiposity, increases glycogen synthesis, and decreases gluconeogenesis (27) .
Bile acids are cycled between the intestine and the liver, creating an enterohepatic cycle that participates in regulating whole body lipid and, in turn, energy homeostasis (7, 36) . After secretion into the intestinal lumen, bile acids are efficiently taken up into ileocytes via the ASBT; their subsequent efflux across the basolateral membrane, a requirement for return to the liver via the portal circulation, is mediated largely by OST␣-OST␤. OST consists of two subunits that heterodimerize for membrane delivery and generation of transport activity (2, 4, 15, 31, 33, 37) . OST␣-OST␤ was originally implicated in the basolateral efflux of bile acids in the ileum on the basis of its substrate specificity, tissue distribution, subcellular localization, and transcriptional regulation (2, 5) . The in vivo functions of the transporter have subsequently been characterized in two Ost␣-deficient (Ost␣ 25). Neonatal Ost␣ Ϫ/Ϫ mice are ϳ25% smaller than wild-type mice, but this difference disappears shortly after weaning (1, 25) . The mechanism for the growth delay in Ost␣ Ϫ/Ϫ mice is unknown. The small intestine is longer and heavier in Ost␣ Ϫ/Ϫ than wild-type mice, with apparent ileal enterocyte dysplasia (1, 13, 25, 32) . Ost␣ Ϫ/Ϫ mice exhibit impaired transileal bile acid absorption coupled with an increase in ileal FGF15 production and a decrease in hepatic Cyp7a1 expression resulting from activation of the FXR in the ileocyte (1, 12, 13, 25) . Ost␣ Ϫ/Ϫ mice have a markedly reduced bile acid pool size and decreased cholesterol and lipid absorption (1, 13, 25) .
Because bile acids serve important roles in regulating lipid levels and glucose handling and initial studies identified potentially beneficial changes in lipid metabolism in Ost␣ Ϫ/Ϫ mice, we set out to establish the role of OST␣-OST␤ in the regulation of lipid and glucose homeostasis in adult (5-mo-old) and aged (12-mo-old) mice. The rationale for studying adult and aged mice was to determine whether the absence of the OST alters the tendency of wild-type C57BL/6 mice to accumulate body fat and become insulin-resistant with age. We show that Ost␣ Ϫ/Ϫ mice are resistant to the age-related accumulation of body fat and decline in insulin sensitivity.
MATERIALS AND METHODS

Animal maintenance. Ost␣
Ϫ/Ϫ mice generated and maintained on a C57BL/6 background (1, 15) were housed in a full-barrier facility with a 12:12-h light-dark cycle and maintained on standard chow (Laboratory Autoclavable Rodent Diet 5010, Purina Mills, St. Louis, MO) containing 12.7 kcal% fat and 0.027% cholesterol. For the cholic acid study, 12-mo-old male mice were fed a modified LabDiet 5001 enriched with 0.2% cholic acid and containing 13.4 kcal% fat and 0.025% cholesterol for 3 wk. Genotyping was performed by PCR analysis of DNA isolated from tail biopsies (1). Mice had free access to food and water, unless otherwise noted. The age of death (in months) for mice that died spontaneously was recorded for the longevity study. Mice were monitored for general health and wellbeing, and mice that exhibited an inability to ambulate, an inability to maintain food or water intake, or clinical signs of pain or illness were removed from the study and euthanized. All procedures were approved by the local Animal Care and Use Committees, according to criteria outlined in the Guide for the Care and Use of Laboratory Animals issued by the Institute of Laboratory Animal Research of the National Academy of Sciences.
Body composition and indirect calorimetry. Body composition and indirect calorimetry studies were conducted at the National Institutes of Health-Yale Mouse Metabolic Phenotyping Center and approved by the Yale University Animal Care and Use Committee. Mice were individually housed under controlled temperature (23°C) and lighting (12:12-h light-dark cycle) with free access to water and fed ad libitum a standard chow (2018S, Harlan Teklad, Indianapolis, IN). Body composition was assessed by 1 H-magnetic resonance spectroscopy (BioSpin, Bruker, Billerica, MA). Whole-body energy metabolism, including O2 uptake, CO2 production, energy expenditure, food and water intake, and locomotor activity, was measured for 72 h by indirect calorimetry (CLAMS, Columbus Instrument, Columbus, OH).
Analysis of organ and fat pad weights. Mice at 5 Ϯ 1 and 12 Ϯ 1 mo of age were fasted for 4 h and then anesthetized with pentobarbital sodium (50 mg/kg ip). Whole-body weights were recorded, and liver, kidney, small intestine, and gonadal and perirenal fat pads were removed and weighed. Where noted, weights are expressed relative to body weight. The small intestine was emptied before measurement.
Analysis of fecal and liver lipids. Feces were collected from mice fed ad libitum and dried overnight. Liver samples were obtained from mice fasted for 4 h. Fecal and liver lipid content was determined gravimetrically (22) . Briefly, 0.5 g of dried feces or 100-to 300-mg pieces of liver were homogenized in water or phosphate-buffered saline and extracted using chloroform-methanol (2:1). Sulfuric acid (0.1%) was added to liver extractions. A portion of the organic phase was dried in a vacuum evaporator to determine lipid mass. Cholesterol was analyzed in liver lipids resuspended in 2% Triton X-100 using an enzymatic assay (Wako Chemicals USA, Richmond, VA).
Bile acid analysis. Dried feces were collected from mice fed ad libitum, and liver samples were obtained from mice restricted from food for 4 h. The bile acid pool samples include liver, gallbladder, and small intestine of mice after an overnight fast, and serum was also collected from mice after an overnight fast. Bile acids were extracted from feces, liver, and bile acid pool samples using methanol as described by Setchell et al. (30) , and total bile acids in serum and tissue samples were analyzed using an enzymatic assay (19) . Where noted, values are expressed relative to tissue wet weight.
Serum lipid analysis. Mice were fasted overnight and anesthetized with pentobarbital sodium (50 mg/kg ip). Whole blood was collected from the vena cava; serum was separated, and total cholesterol, HDL, LDL, and triglycerides were analyzed using enzymatic kits from Wako Chemicals or Thermo Fisher and nonesterified free fatty acids were analyzed using an enzymatic kit from Zenbio (Research Triangle Park, NC).
Glucose and insulin tolerance tests. Overnight-fasted mice were used for glucose tolerance tests (GTTs). At 7 AM, mice were anesthetized using isoflurane, their tails were snipped, and the mice were allowed to recover for 2 h. Glucose was administered (1 mg/g ip), and tail blood glucose was measured at 0, 15, 30, 60, 90, and 120 min using a OneTouch Ultra glucometer. Additional blood was collected at 0, 30, 60, and 90 min for an insulin ELISA (Crystal Chem, Chicago, IL). For insulin tolerance tests (ITTs), mice were fasted for 6 h (morning to afternoon) and anesthetized, and insulin was administered (1.5 U/kg ip); glucose levels were measured as described above.
Analysis of Akt phosphorylation. Male and female 12-mo-old wild-type and Ost␣ Ϫ/Ϫ mice were fasted overnight. After they were anesthetized with pentobarbital sodium (50 mg/g ip), the mice were injected with saline or insulin (1.5 U/kg, the dose used in the ITTs), and liver and quadriceps were removed 10 min postinjection and immediately snap-frozen in liquid nitrogen. Frozen tissues were homogenized using an Ultra Turrax homogenizer in lysis buffer (150 mM NaCl, 1.0% Triton X-100, 50 mM Tris, pH 8.0, mammalian protease and phosphatase inhibitor cocktails, and 5 mM activated sodium orthovanadate) and centrifuged at 20,000 g for 20 min. Protein concentration was measured using the Lowry assay (17) . Western blots were performed as follows: 30 g of protein were run on a 10% polyacrylamide gel and transferred to a polyvinylidene difluoride membrane. Milk (5%) was used as a blocking agent, and primary antibodies to Akt1/2 (catalog no. sc-1619-r, Santa Cruz Biotechnology, Santa Cruz, CA) or phosphorylated (Ser 473 ) Akt (catalog no. 4060, Cell Signaling Technology, Danvers, MA) were used at 1:200 and 1:2,500 dilutions, respectively. Bands were visualized using secondary horseradish peroxidase-conjugated antibody to rabbit IgG at 1:5,000 dilution and the LumiGlo system (Kirkegaard & Perry Laboratories, Gaithersburg, MD).
Total mRNA isolation from mouse tissues. Liver and intestine were removed from anesthetized mice fasted for 4 h. The intestine was sectioned into three equal-length pieces, and the contents were removed. Total RNA was isolated from these tissues using guanidinium thiocyanate-cesium chloride and treated with DNase I (Fermentas/ Thermo Scientific).
Real-time quantitative reverse-transcriptase PCR analyses. Genespecific oligonucleotide primers were designed using National Center for Biotechnology Information Primer-BLAST and purchased from Integrated DNA Technologies (Coralville, IA) and sequences are available on request. Each primer pair was tested using liver and/or Values are means Ϯ SE (n ϭ 6 -7). V O2, O2 uptake; V CO2, CO2 output. *P Ͻ 0.05 vs. wild-type.
small intestine mRNA and a Superscript One-Step RT-PCR kit (Life Technologies, Carlsbad, CA) on a ThermoHybaid Px2 RT-PCR unit. The resulting PCR product was separated by gel electrophoresis, and the cDNA product was extracted with a kit from Qiagen (Valencia, CA) and diluted to produce gene-specific cDNA standards containing 10 -10 7 copies diluted in yeast total RNA. Relative gene expression was determined on a real-time cycler (Rotor-Gene 3000, Corbett, San Francisco, CA). Samples (n ϭ 6 -7) were analyzed in duplicate using an iScript one-step reversetranscriptase PCR kit with SYBR Green (Bio-Rad, Hercules, CA) or Stratagene Brilliant III Ultra-Fast SYBR Green QRT-PCR Master Mix (Agilent Technologies, Santa Clara, CA). A 50-ng sample of total RNA was analyzed per reaction.
Statistical analyses. Values are means Ϯ SE. Mean values were considered to be significantly different when P Ͻ 0.05 by two-way ANOVA followed by Tukey's or Bonferroni's multiple comparisons test or Student's t-test where applicable.
RESULTS
Decreased weight gain and fat accumulation in Ost␣
Ϫ/Ϫ mice. Interestingly, body weights were lower and perirenal and gonadal fat pads were smaller in male Ost␣ Ϫ/Ϫ mice as they matured through adulthood (Fig. 1, A and B) . Differences in body weight and fat pad weight were also observed in female mice (Fig. 2, A and B) , but the differences between genotypes were not as dramatic, because female wild-type mice did not exhibit the age-related weight gain to the extent of male wild-type mice. The small intestines of Ost␣ Ϫ/Ϫ mice were heavier than those of wild-type animals at 5 mo (males: indicate that Ost␣ Ϫ/Ϫ mice display ileocyte enterocyte dysplasia at an early age that persists but does not appear to worsen as the animals age (Soroka and Boyer, unpublished data). In male and female mice, liver and kidney weights were similar for both genotypes at both ages (data not shown). Male Ost␣ Ϫ/Ϫ mice lived significantly longer than wild-type mice (Fig. 1C) , whereas female Ost␣ Ϫ/Ϫ and wild-type mice had similar lifespans (Fig. 2C) .
Altered energy utilization in Ost␣ Ϫ/Ϫ mice. At 5 mo of age, male Ost␣ Ϫ/Ϫ mice had ϳ5% lower total body fat and 4% higher lean body mass than male wild-type mice (Table 1) . These changes were not due to a decrease in food consumption or an increase in activity of Ost␣ Ϫ/Ϫ mice, although Ost␣ Ϫ/Ϫ mice did consume more water than their wild-type counterparts. The respiratory quotient was also higher for Ost␣ Ϫ/Ϫ mice, indicating that more carbohydrates were utilized for energy. The increase in the respiratory quotient occurred during the light cycle while the mice were at rest.
Lipid and bile acid levels in Ost␣
mice excreted more lipids in feces than wild-type mice at 5 and 12 mo of age (Fig. 3A) . Fecal bile acid excretion was similar in both genotypes and remained unchanged between 5 and 12 mo (Fig. 3B ). Liver total lipid and cholesterol content increased with age in male wild-type, but not Ost␣
, mice (Fig. 3 , C and E). Liver bile acids were also lower in male Ost␣ Ϫ/Ϫ mice (Fig. 3D) , likely due to lower Cyp7a1 expression and bile acid synthesis (1, 25) . The bile acid pool decreased with age in the wild-type, but not Ost␣ Ϫ/Ϫ , mice and was much smaller in male Ost␣ Ϫ/Ϫ mice at both ages (Fig. 3F) . Skeletal muscle total lipid (Fig. 3G) and triglyceride (Fig. 3H ) content were lower in 5-and 12-mo-old male Ost␣ Ϫ/Ϫ than wild-type mice and increased with age in both genotypes.
Female Ost␣ Ϫ/Ϫ mice also excreted more lipids than wildtype mice at 12 mo of age (Fig. 4A) . Female knockout mice tended to have lower fecal and liver bile acids by 12 mo of age (Fig. 4, B and D) . In female mice, the effects of age and genotype on total lipid and cholesterol in liver were small relative to the differences in male mice (Fig. 4, C and E) . Total lipid and triglyceride contents in skeletal muscle of female mice were not affected by age or genotype (Fig. 4, G and H) . The bile acid pool of female mice was unchanged with age but, as with males, was dramatically lower in Ost␣ Ϫ/Ϫ animals (Fig. 4F) .
Serum chemistry in Ost␣ Ϫ/Ϫ mice. To determine whether the increase in fecal lipid excretion led to decreased serum lipids and whether the decrease in bile acid pool size was reflected in serum bile acids, total cholesterol, HDL, LDL, triglycerides, free fatty acids, and bile acids were measured in serum from 5-and 12-mo-old mice ( Table 2) . Total serum cholesterol increased modestly with age in males, but there were no statistically significant differences between wild-type and Ost␣ Ϫ/Ϫ mice in any of these parameters, except for higher serum bile acids in 5-mo-old female Ost␣ Ϫ/Ϫ mice. It is noteworthy that the results from mature female mice differ from previously reported findings from younger female Ost␣ Ϫ/Ϫ mice, which showed lower serum cholesterol and triglyceride levels in Ost␣ Ϫ/Ϫ than wild-type mice (1, 25) .
Expression of genes involved in dietary lipid absorption.
Gene expression was analyzed by real-time PCR using RNA obtained from liver and the proximal, middle, and lower third of the small intestine from 5-and 12-mo-old male wild-type and Ost␣ Ϫ/Ϫ mice. The amount of each mRNA relative to actin mRNA and the expression of each mRNA in Ost␣ Ϫ/Ϫ relative to wild-type mice is given in Tables 3 and 4 .
Analysis of genes involved in intestinal lipid absorption revealed changes consistent with decreased dietary lipid absorption in Ost␣ Ϫ/Ϫ mice (Table 3 ). In 5-and 12-mo-old mice, mRNAs encoding the apical cholesterol uptake transporter Niemann-Pick C1-like 1 (Npc1L1) in the distal intestinal segment and the basolateral cholesterol efflux transporter ATPbinding cassette transporter 1 (Abca1) in each intestinal section were lower in Ost␣ Ϫ/Ϫ mice, in agreement with a previous study of ileal Npc1L1 and Abca1 in 3-mo-old male mice (13) .
Hepatic expression of the cholesterol synthetic genes hydroxymethylglutaryl-CoA reductase (Hmgcr), mevalonate (diphospho) decarboxylase (Mvd), and farnesyldiphosphate farnesyltransferase (Fdft) was significantly upregulated in Ost␣ Ϫ/Ϫ mice ( Table 4 ), suggesting that reduced dietary cholesterol absorption was partially compensated by increased cholesterol synthesis. The expression of Srebp1a and Srebp2, which activate lipogenic and cholesterogenic enzymes, was unchanged in the livers of Ost␣ Ϫ/Ϫ mice, whereas the expression of Srebp1c, the major transcriptional activator for lipogenic enzymes, was lower. However, several genes downstream of SREBP1c [Fas, acetyl-CoA carboxylase-␣ and -␤ (Acaca and Acacb), diglyceride acyltransferase (Dgat2), and glycerol-3-phosphate acyltransferase (Gpat)] were either unaffected or upregulated. This may be partly due to the actions of LIPIN 1, a transcriptional coactivator of lipid homeostasis genes (3, 23) . mRNA encoding LIPIN 1 was significantly increased in the livers of 5-moold Ost␣ Ϫ/Ϫ mice. Overall, enhanced hepatic Lpin1 expression in Ost␣ Ϫ/Ϫ mice is consistent with increased hepatic triglyceride synthesis necessary to restore triglyceride and fatty acid homeostasis in the face of impaired dietary lipid absorption.
Expression of FXR-related genes. To examine the possibility of altered FXR activation in male Ost␣ Ϫ/Ϫ mice, expression of Fxr and Shp1 was measured in liver and small intestine sections and expression of the FXR target gene Fgf15 and the ileal bile acid-binding protein (IBABP) gene Ibabp and the bile acid transporters Asbt and multidrug resistance-associated protein 3 (Mrp3) in small intestine sections from 5-and 12-mo-old mice. In Ost␣ Ϫ/Ϫ mice, Fxr was not significantly altered in the liver or small intestine, whereas Shp1 was unchanged in the liver but strongly increased in the middle and distal segments of the small intestine at 5 and 12 mo and in the proximal section of the small intestine at 12 mo.
Patterns of expression of FXR target genes were complex. Fgf15 expression was highest in the distal section of the small intestine but was not significantly affected by age or the absence of OST␣-OST␤. FGF15 protein, however, is dramatically increased in the ileum of young adult Ost␣ Ϫ/Ϫ mice (13). Remarkably, Ibabp expression was increased by 60-to 100-fold in the middle section and ϳ2-fold in the distal section of the small intestine in Ost␣ Ϫ/Ϫ mice of both ages. However, Ibabp expression was by far the highest in the distal small intestine (Table 3) . Because the small intestine was sectioned into equal thirds and Ost␣ Ϫ/Ϫ mice have elongated ileums and relatively normal-length jejunums and duodenums (13) , there was probably more ileal tissue in the middle sections of small intestine from Ost␣ Ϫ/Ϫ mice, accounting for the apparent increase in Ibabp expression in those sections.
Expression of the bile acid transporter Asbt was unchanged or mildly upregulated in 5-and 12-mo-old Ost␣ Ϫ/Ϫ mice, with undetectable expression in the proximal sections. This finding was unexpected, because ASBT protein is markedly lower in the ileum of Ost␣ Ϫ/Ϫ mice (13, 32), possibly because protein levels were measured in younger animals. Mrp3 expression was higher in the middle and distal sections of small intestine from Ost␣ Ϫ/Ϫ mice at 5 mo and increased in the distal section at 12 mo. This upregulation of Mrp3 presumably partially compensates for the loss of the OST and is similar to findings in previous studies of male and female Ost␣ Ϫ/Ϫ mice (25, 32) . Mrp3 expression increased with age in the proximal and middle sections of small intestine from wild-type, but not Ost␣ Ϫ/Ϫ , mice (Table 3) . 
Improved glucose tolerance and insulin sensitivity in Ost␣
Ϫ/Ϫ mice. Intracellular lipid metabolites and bile acids have been shown to affect insulin action and glucose tolerance (14, 26) . GTTs and ITTs were performed on 5-and 12-mo-old male (Fig. 5) and female (Fig. 6) mice. Interestingly, subtle improvements in glucose tolerance, as evidenced by lower blood glucose levels 15, 30, 60, and 90 min after glucose injection at 5 and 12 mo of age, were observed in male Ost␣ Ϫ/Ϫ mice (Fig. 5, A-D) . Plasma insulin concentrations during the GTTs were similar in 5-mo-old mice (Fig. 5E ), as were the declines in plasma glucose during the ITTs (Fig. 5G) .
In 12-mo-old mice, although the differences in glucose tolerance were diminished, there were marked differences in the insulin responses. Fasting plasma insulin concentrations were higher in wild-type than Ost␣ Ϫ/Ϫ mice (Fig. 5F ). In addition, the glucose challenge resulted in higher plasma insulin concentrations in wild-type mice at 12 than 5 mo of age, whereas Ost␣ Ϫ/Ϫ mice produced similar low levels of insulin at 5 and 12 mo of age. There was also a greater reduction in plasma glucose during the ITT in 12-mo-old Ost␣ Ϫ/Ϫ than wild-type mice (Fig. 5H) . These results suggest that aged Ost␣ Ϫ/Ϫ mice are protected from age-associated decreases in insulin sensitivity.
Glucose tolerance was not significantly different between female wild-type and Ost␣ Ϫ/Ϫ mice at either age (Fig. 6, A-D) . Insulin levels were lower in female Ost␣ Ϫ/Ϫ than wild-type mice at 5 and 12 mo (Fig. 6, E and F) , and ITTs in female mice suggested improved insulin sensitivity at 5 mo (Fig. 6G) . The major difference between male and female animals, however, was that wild-type females did not undergo the same age- related increase in insulin levels as males (cf. Fig. 5 , E and F, and Fig. 6, E and F) . These results may reflect the fact that female mice did not undergo the same age-related fat accumulation and increased liver and muscle lipids as their male counterparts.
Intestinal bile acid levels determine lipid excretion in Ost␣
Ϫ/Ϫ mice. Lipid excretion was increased and glucose tolerance and insulin responsiveness were improved in male Ost␣ Ϫ/Ϫ compared with wild-type mice. Bile acid levels were also decreased in liver, gallbladder, and small intestine in Ost␣ Ϫ/Ϫ mice, and bile acid levels and composition are known to play a role in fat absorption and glucose homeostasis. To determine the contribution of bile acid levels to lipid absorption and insulin sensitivity, male mice were fed a diet enriched in 0.2% cholic acid for 3 wk. The cholic acid diet did not affect food consumption, fecal production, or the differences in body and fat pad weight between wild-type and Ost␣ Ϫ/Ϫ mice (data not shown). The cholic acid diet did introduce enough bile acid into the lumen of the small intestine to reduce fecal lipid excretion in Ost␣ Ϫ/Ϫ mice to levels measured in wild-type mice (Fig. 7A) . Glucose responses were the same for both genotypes with or without the addition of cholic acid (Fig. 7, B  and C) . However, the amount of insulin produced during the GTT did differ between wild-type and Ost␣ Ϫ/Ϫ mice, with Ost␣ Ϫ/Ϫ mice displaying substantially lower insulin levels before and after glucose administration (Fig. 7, D and E) . Insulin levels were higher after glucose injection in Ost␣ Ϫ/Ϫ mice fed the cholic acid diet than in Ost␣ Ϫ/Ϫ mice fed standard chow but were still below levels measured in wild-type mice (Fig. 7E) .
Improved insulin responses in liver and muscle in Ost␣
mice. Akt is phosphorylated downstream of insulin receptor activation; therefore, Akt phosphorylation provides a direct measure of insulin responsiveness. Wild-type and Ost␣ Ϫ/Ϫ mice at 12 mo of age were injected with saline or insulin, and liver and skeletal muscle tissue were collected 10 min later for immunoblot analysis of total and phosphorylated Akt. In male liver tissue, insulin-injected wild-type mice showed a 2.2-fold increase in phosphorylated Akt [ratio of phosphorylated to total Akt (p-Akt/Akt)] compared with their salineinjected counterparts, whereas Ost␣ Ϫ/Ϫ mice showed a 3.3-fold increase (Fig. 8) . Liver tissue from female mice showed similar responses to insulin, with 2.9-fold (wild-type) and 3.5-fold (Ost␣ Ϫ/Ϫ ) increases in Akt phosphorylation (Fig. 9) . Interestingly, p-Akt/Akt levels were lower in skeletal muscle tissue from saline-injected Ost␣ Ϫ/Ϫ than saline-injected wild-type mice, indicating lower basal Akt phosphorylation in male and female Ost␣ Ϫ/Ϫ mice. Whereas male and female wild-type mice showed 2.0-and 2.3-fold increases in skeletal muscle p-Akt/Akt following insulin injection, muscle tissue from male and female Ost␣ Ϫ/Ϫ mice showed significantly stronger responses (5.3-and 9.9-fold for males and females, respectively).
DISCUSSION
The present study indicates that the loss of OST␣-OST␤ has beneficial effects on lipid and glucose homeostasis. Ost␣ Ϫ/Ϫ mice were protected from age-related weight gain, and male mice, which gain more weight than female mice during aging, demonstrated improved glucose tolerance and insulin sensitivity, as well as increased lifespan. Interestingly, caloric intake and activity levels in the Ost␣ Ϫ/Ϫ and wild-type mice were similar and do not account for the lower body fat and higher lean body mass of the Ost␣ Ϫ/Ϫ mice. In contrast, increased fecal lipid excretion in the Ost␣ Ϫ/Ϫ mouse, which indicates a defect in lipid absorption, may be an important mechanism contributing to decreased fat accumulation.
Ost␣ Ϫ/Ϫ mice had lower bile acid levels in the enterohepatic circulation at 5 and 12 mo of age. Ost␣ Ϫ/Ϫ mice also have an altered bile acid pool composition, with a lower percentage of cholic acid and a smaller hydrophobic bile acid pool (13) . Bile acids facilitate the formation of micelles with dietary choles- terol and other lipid constituents, allowing their absorption, and micelle formation is favored by more hydrophobic bile acids. The changes in bile acid pool size and composition explain why cholesterol and lipid absorption from the small intestine are reduced in Ost␣ Ϫ/Ϫ mice and other mouse models with similar phenotypes (the Cyp7a1 Ϫ/Ϫ mouse and mice with activated FXR or increased FGF15) (10, 29, 37, 38) . Increased fecal lipid excretion in Ost␣ Ϫ/Ϫ mice depended on reduced levels or altered composition of bile acids in the intestinal lumen, because supplementation with 0.2% cholic acid returned lipid excretion to levels measured in wild-type mice. These results confirm a previous report by Lan et al. (13) . The decrease in fecal lipid excretion caused by cholic acid feeding was accompanied by, at most, a partial reversal of the improved glucose tolerance and insulin sensitivity in Ost␣ Ϫ/Ϫ mice fed normal chow. This result, obtained when overall body weight and composition were unchanged by the diet, shows that increased lipid excretion in Ost␣ Ϫ/Ϫ mice does not fully account for their improved glucose tolerance and insulin sensitivity. . Glucose tolerance and insulin sensitivity in female mice. Glucose tolerance tests were performed in 5-mo-old (A, C, and E) and 12-mo-old (B, D, and F) mice following an overnight fast. Glucose (1 mg/g ip) was administered, and tail blood was analyzed for glucose at 15-to 30-min intervals. In E and F, additional blood was collected from tail snips at 0, 30, 60, and 90 min for insulin analysis. G and H: insulin tolerance tests in 5-and 12-mo-old mice following a 6-h fast. Insulin (1.5 U/kg ip) was administered, and tail blood was analyzed for glucose at 15-to 30-min intervals. Body weights of 5 mo-old wild-type and Ost␣ Ϫ/Ϫ mice were 28 Ϯ 4 and 23 Ϯ 2 g, respectively, whereas 12-moold wild-type and Ost␣ Ϫ/Ϫ mice weighed 30 Ϯ 3 and 25 Ϯ 2 g, respectively. C and D: total area under the curve relative to wild-type mice. Values are means Ϯ SE (n ϭ 9 -10). *P Ͻ 0.05 vs. wild-type.
Despite decreased lipid absorption in Ost␣ Ϫ/Ϫ mice, circulating levels of cholesterol, triglycerides, and fatty acids were not reduced. Synthesis of cholesterol, triglycerides, and fatty acids may have increased to maintain levels measured in wild-type mice. Significant increases in hepatic expression of the cholesterol synthesis genes Hmgcr, Mvd, and Fdft were observed in Ost␣ Ϫ/Ϫ mice, as were small increases in Srebp2. However, expression of the repressor of cholesterol synthesis insulin-induced gene 1 (Insig1) was also increased. The altered expression of genes involved in cholesterol synthesis did not raise hepatic cholesterol levels; in fact, liver cholesterol was lower in Ost␣ Ϫ/Ϫ than wild-type mice at 12 mo of age. Patterns of lipogenic gene expression in the Ost␣ Ϫ/Ϫ mouse were also difficult to interpret. Srebp1c was decreased, implying that lipogenesis is lower in the Ost␣ Ϫ/Ϫ mice, but several downstream targets of SREBP1c (Fas, Acaca, Acacb, Dgat2, and GpatI) were not. Interestingly, the Cyp7a1 Ϫ/Ϫ mouse, like the Ost␣ Ϫ/Ϫ mouse, has a markedly reduced bile acid pool due to deficient synthesis and a resulting defect in cholesterol absorption, but cholesterol levels are not reduced because of a compensatory increase in cholesterol synthesis (28, 29) .
The decrease in bile acid synthesis in Ost␣ Ϫ/Ϫ models has been attributed to hyperplasia of the ileum, providing increased opportunities for bile acid-mediated signaling events. Increased ileal FXR signaling results in increased FGF15, which enters the enterohepatic circulation and acts via FGF receptor 4 in the liver to decrease Cyp7a1 mRNA expression and bile acid synthesis. The central role of FXR signaling was confirmed by Lan et al. (13) , who showed lower FGF15, higher Cyp7a1 mRNA, and larger bile acid pools in double-knockout mice lacking Ost␣ and Fxr than mice lacking Ost␣ alone. Increased bile acid signaling through FXR may also be potentiated through the increase in IBABP in the ileum of the Ost␣ Ϫ/Ϫ mouse. Bile acids bound to IBABP activate FXR within the ileum (6, 20) , and signaling by less hydrophobic bile acids, such as those present in Ost␣ Ϫ/Ϫ mice, is facilitated by IBABP (6) .
Important findings in this study are improved glucose tolerance and insulin sensitivity in male Ost␣ Ϫ/Ϫ mice, particularly as they age. Several factors may explain how the altered bile acid and lipid homeostasis in Ost␣ Ϫ/Ϫ mice protect from age-related insulin resistance. Lipid (specifically diacylglycerol) accumulation in insulin-responsive tissues can activate nPKCs, with subsequent impairment of insulin signaling (27) . Male Ost␣ Ϫ/Ϫ mice had reduced body fat and hepatic and skeletal muscle lipid content combined with normal or increased lean body mass. This was associated with improved insulin sensitivity in older mice, as reflected by a reduction in insulin secretion during the GTT and a greater decrease in plasma glucose during the ITT. These improvements could be attributed to improvements in insulin signaling, as insulin-stimulated Akt phosphorylation was enhanced in the Ost␣ Ϫ/Ϫ mice. In contrast, female mice accumulated less body fat than male mice as they aged. Female wild-type mice did not display an age-dependent increase in skeletal muscle lipid Ϫ/Ϫ mice were fed a diet enriched with 0.2% cholic acid. A-C: fecal lipid excretion was measured (n ϭ 5; A) and glucose tolerance tests (n ϭ 9 -11) were performed before (B) and 1 wk after (C) the animals were switched to the cholic acid-enriched diet (n ϭ 5). D and E: insulin levels during the glucose tolerance tests. Values are means Ϯ SE. *P Ͻ 0.05 vs. wild-type.
content. Female Ost␣ Ϫ/Ϫ mice exhibited only minor improvements in glucose handling compared with their wildtype counterparts; however, 12-mo-old female Ost␣ Ϫ/Ϫ mice showed a stronger phosphorylated Akt response to insulin than female wild-type mice of the same age. Taken together, the data support the conclusion that reduced ectopic lipid accumulation in the Ost␣ Ϫ/Ϫ mice enhances insulin signaling and insulin sensitivity.
Bile acids have recently been shown to regulate glucose homeostasis by signaling through FXR and other pathways. FXR Ϫ/Ϫ mice have impaired glucose tolerance and insulin sensitivity and increased fasting blood glucose and serum Fig. 8 . Insulin-induced phosphorylated Akt (p-Akt) and total Akt expression in liver and muscle tissue from male mice. Male 12-moold wild-type and Ost␣ Ϫ/Ϫ mice were fasted overnight. At 10 min after intraperitoneal injection of insulin (1.5 U/kg) or saline, liver (A) and muscle (B) tissue were removed, and Akt phosphorylation was analyzed by Western blotting. Graphs represent densitometric values of p-Akt-to-Akt expression ratio relative to average insulin-stimulated wild-type p-Akt-to-Akt ratio. Values are means Ϯ SE (n ϭ 6, each analyzed 3 separate times). *P Ͻ 0.05. Fig. 9 . Insulin-induced p-Akt and Akt expression in liver and muscle tissue of female mice. Female 12-mo-old wild-type and Ost␣ Ϫ/Ϫ mice were fasted overnight. At 10 min after intraperitoneal injection of insulin (1.5 U/kg) or saline, liver (A) and muscle (B) tissue were removed, and Akt phosphorylation was analyzed by Western blotting. Graphs represent densitometric values of pAkt-to-Akt expression ratio relative to average insulin-stimulated wild-type p-Akt-toAkt ratio. Values are means Ϯ SE (n ϭ 4 -5, analyzed 3 separate times). *P Ͻ 0.05. triglyceride levels (18) . FXR activation and adenoviral-mediated overexpression of constitutively active FXR improve these parameters in genetic diabetic obese mouse models (14, 18) . It is thought that these effects of bile acids are, in part, mediated through FGF15/19 produced in response to intestinal FXR activation. Transgenic mice expressing FGF19 are resistant to the diabetogenic effects of a high-fat diet and display improved glucose tolerance and insulin sensitivity (35) , and Fgf15 Ϫ/Ϫ mice have impaired glucose tolerance that can be restored by FGF19 treatment (11) . FGF15/19 inhibits gluconeogenesis by inhibiting the cAMP response element-binding protein-peroxisome proliferator-activated receptor-␥ coactivator-1␣ pathway and increases glycogen synthesis by activating glycogen synthase (11, 24) . Because Ost␣ Ϫ/Ϫ mice produce more FGF15 than their wild-type counterparts (13) , it is likely that FGF15 also contributes to the improvement in glucose tolerance.
The main findings of this study are summarized in Fig. 10 . Regardless of age, Ost␣ Ϫ/Ϫ mice exhibit a phenotype consistent with impaired dietary lipid absorption: reduced bile acid pools and increased fecal lipids. Gene expression of the cholesterol uptake transporter Npc1L1 and the efflux transporter Abca1 are decreased in the small intestine of Ost␣ Ϫ/Ϫ mice. Expression of the bile acid transporter Mrp3 is increased, partially compensating for the loss of OST␣-OST␤. This study confirms previous work showing that the loss of OST␣-OST␤ and the subsequent reduction in bile acid pool size impair dietary lipid absorption and alter bile acid signaling pathways and demonstrates that these effects persist throughout life. A novel and important discovery is that mice lacking OST␣-OST␤ gain less weight, accumulate less lipid in liver and skeletal muscle, and remain more insulinsensitive as they age, providing compelling evidence that OST␣-OST␤ is a physiological regulator of carbohydrate, as well as lipid, metabolism.
